Title: Early Serum Infliximab Trough Level, Clinical Disease Activity and CRP as Markers of Sustained Benefit of Infliximab Treatment in Crohn's Disease: A Post-hoc Analysis of the ACCENT1 Trial
Authors: Cornillie, F
Hanauer, Stephen
Diamond, R
Wang, J
Zelinger, D
Xu, Z
Vermeire, Severine
Rutgeerts, Paul #
Issue Date: Oct-2011
Publisher: Nature Publishing Group
Host Document: American Journal of Gastroenterology vol:106 pages:S462-S463
Conference: - edition:- location:- date:-
ISSN: 0002-9270
Publication status: published
KU Leuven publication type: IMa
Appears in Collections:Translational Research in GastroIntestinal Disorders
# (joint) last author

Files in This Item:

There are no files associated with this item.


All items in Lirias are protected by copyright, with all rights reserved.